Medical Cannabis Payment Solutions (OTCMKTS:REFG) & CompoSecure (NASDAQ:CMPO) Head-To-Head Contrast

Medical Cannabis Payment Solutions (OTCMKTS:REFGGet Free Report) and CompoSecure (NASDAQ:CMPOGet Free Report) are both business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Medical Cannabis Payment Solutions and CompoSecure, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medical Cannabis Payment Solutions 0 0 0 0 0.00
CompoSecure 0 0 6 0 3.00

CompoSecure has a consensus price target of $25.50, suggesting a potential upside of 99.22%. Given CompoSecure’s stronger consensus rating and higher possible upside, analysts clearly believe CompoSecure is more favorable than Medical Cannabis Payment Solutions.

Valuation and Earnings

This table compares Medical Cannabis Payment Solutions and CompoSecure”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medical Cannabis Payment Solutions N/A N/A N/A N/A N/A
CompoSecure $160.68 million 10.07 -$53.72 million ($2.16) -5.93

Medical Cannabis Payment Solutions has higher earnings, but lower revenue than CompoSecure.

Insider & Institutional Ownership

37.6% of CompoSecure shares are owned by institutional investors. 52.1% of CompoSecure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Medical Cannabis Payment Solutions has a beta of -0.65, indicating that its share price is 165% less volatile than the S&P 500. Comparatively, CompoSecure has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

Profitability

This table compares Medical Cannabis Payment Solutions and CompoSecure’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medical Cannabis Payment Solutions N/A N/A N/A
CompoSecure -24.53% -65.50% 26.83%

Summary

CompoSecure beats Medical Cannabis Payment Solutions on 8 of the 10 factors compared between the two stocks.

About Medical Cannabis Payment Solutions

(Get Free Report)

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

About CompoSecure

(Get Free Report)

CompoSecure, Inc. manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others. In addition, it offers Payments + Arculus Secure Authenticate, white-labeled cold storage wallet, Payments + Arculus Cold Storage, and Payments + Arculus Authentication + Arculus Cold Storage. The company serves financial institutions, plastic card manufacturers, system integrators, and security specialists. CompoSecure, Inc. was founded in 1910 and is based in Somerset, New Jersey.

Receive News & Ratings for Medical Cannabis Payment Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Cannabis Payment Solutions and related companies with MarketBeat.com's FREE daily email newsletter.